GoodRx Holdings (GDRX) Change in Receivables (2019 - 2026)

GoodRx Holdings has disclosed Change in Receivables across 8 years of filings, most recently posting -$50.6 million for Q2 2026.

• In Q2 2026, Change in Receivables fell 274.96% year-over-year to -$50.6 million; the TTM figure through Jun 2026 stood at -$8.7 million (down 131.86% YoY), while the FY2025 annual figure was $88.0 million, up 3684.01% from the prior year.
• Change in Receivables came in at -$50.6 million for Q2 2026 at GoodRx Holdings, down from -$3.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $30.2 million in Q4 2025 to a low of -$50.6 million in Q2 2026.
• Average Change in Receivables over 5 years is $3.4 million, with a median of $3.2 million recorded in 2022.
• Year-over-year, Change in Receivables slumped 1287.59% in 2024 and jumped 1121.62% in 2025.
• Over 5 years, Change in Receivables stood at -$3.7 million in 2022, then jumped by 699.79% to $22.5 million in 2023, then tumbled by 32.64% to $15.1 million in 2024, then surged by 99.67% to $30.2 million in 2025, then slumped by 267.42% to -$50.6 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$50.6 million in Q2 2026, -$3.0 million in Q1 2026, and $30.2 million in Q4 2025.